Morgan Stanley sets USD 21.00 target for NOV stock

Published on 10/15/2026 at 21:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

A Hold rating and USD 21.00 target followed on October 14, 2026. NOV stock costs EUR 16.65 on October 15, 2026, while NYSE NOV fell 0.69 percent.

Analyst view and trading date

Morgan Stanley kept a Hold rating and set a USD 21.00 target on October 14, 2026.
NOV will publish third-quarter results on October 27, 2026, before its October 28 conference call.
NOV stock costs EUR 16.65 at Lang & Schwarz on October 15, 2026 at 9:38 p.m. CEST; the NYSE quote was down 0.69 percent versus its prior close.
NOV had a P/E ratio of 71.75 and a market capitalization of USD 6.6 billion as of October 15, 2026.

NOV, US62955J1034, Illustration mit AI erstellt.

Morgan Stanley kept a Hold rating on NOV and set a USD 21.00 price target on October 14, 2026, according to Markets Insider. Against the NYSE quote of USD 18.62 on October 15, 2026, that target was 12.78 percent higher. NOV stock was trading at EUR 16.65 at Lang & Schwarz on October 15, 2026 at 9:38 p.m. CEST.

Results date sets the next marker

NOV plans to release third-quarter 2026 results after the NYSE session on October 27, 2026, followed by its earnings conference call on October 28. The company listed the call at 11:00 a.m. EDT in its investor-relations calendar, while MarketScreener reported the release and call schedule on September 16, 2026.

Revenue reached USD 2.13 billion

For the second quarter of 2026, NOV generated USD 2.13 billion in revenue, operating profit of USD 193.0 million and net income of USD 112.0 million. Diluted earnings per share came to USD 0.31, while revenue was USD 2.19 billion in the year-earlier quarter, according to Markets Insider. The comparison points to a 2.74 percent year-over-year revenue decline, even as net income increased from USD 108.0 million.

Trading range and valuation

The NYSE quote was down 0.69 percent from its USD 18.75 prior close on October 15, 2026. NOV traded between USD 18.24 and USD 18.78 during the session, with volume of 2,852,186 shares against an average of 3,361,029.

NOV's 52-week range was USD 11.65 to USD 21.93, and its market capitalization was USD 6.6 billion as of October 15, 2026. The P/E ratio was 71.75. The latest company figures and the October reporting schedule give the next earnings release greater weight than the daily price move.

Comparison with peers

NOV (NYSE, USD): minus 0.69 percent, P/E 71.75, market capitalization USD 6.6 billion
SLB (NYSE, USD): minus 0.70 percent, P/E 23.51, market capitalization USD 71.5 billion
Halliburton Company (NYSE, USD): minus 0.38 percent, P/E 17.15, market capitalization USD 27.2 billion

Price and investor dates

On October 15, 2026, the NYSE quote placed NOV below its USD 21.00 Morgan Stanley target, while the euro quotation remained in after-hours trading. The next scheduled company dates are October 27, 2026 for the results release and October 28, 2026 for the conference call.

NOV stock costs EUR 16.65 at Lang & Schwarz on October 15, 2026 at 9:38 p.m. CEST; the NYSE quote was down 0.69 percent versus its prior close of October 14, 2026. The further course of trading is shown by the continuously updated real-time quote of NOV stock.